Effect of recombinant human endostatin on endometriosis in mice

Chinese Medical Journal

Volumn 120, Issue 14, 2007, Pages 1241-1246

  Jiang, Hong Qing ^a   Li, Ya Li ^a   Zou, Jie ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Animal model; Endometriosis; Recombinant human endostatin

Indexed keywords

ENDOSTATIN; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG; VASCULOTROPIN; YH 16;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MICROSCOPY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; SCID MOUSE; TISSUE DEGENERATION; TISSUE GROWTH; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 34547819713     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200707020-00007     Document Type: Article

References (30)

1. Garry R, Clayton R, Hawe J. The effect of endometriosis and its radical laparoscopic excision on quality of life indicators. Br J Obstet Gynaecol 2000; 107: 44-54.
2. Yanushpolsky EH, Best CL, Jackson KV, Clarke RN, Barbieri RL, Hornstein MD. Effects of endometriomas on oocyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet 1998; 15: 193-197.
3. Maas JWM, Groothuis PG, Dunselman GAJ, De Goeij AFPM, Struijker Boudier HAJ, Evers JLH. Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick chorioallantoic membrane. Hum Reprod 2001; 16: 627-631.
4. Cheung TH, Lo KW, Yim SF, Lam C, Lau E, Haines C. Dose effects of progesterone in add-back therapy during GnRHa treatment. J Reprod Med 2005; 50: 35-40.
5. Maas JWM, Groothuis PG, Dunselman GAJ, De Goeij AFPM, Struijker Boudier HAJ, Evers JLH. Endometrial angiogenesis throughout the human menstrual cycle. Hum Reprod 2001; 16: 1557-1561.
6. Maas JWM, Le Noble FAC, Dunselman GAJ, De Goeij AF, Struyker Boudier HA, Evers JL. The chick chorioallantoic membrane as a model to investigate the angiogenic properties of human endometrium. Gynecol Obstet Invest 1999; 4: 108-112.
7. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
8. Awwad JT, Sayegh RA, Tao XJ, Hassan T, Awwad ST, Isaacson K. The SCID mouse:an experimental model for endometriosis. Hum Reprod 1999; 14: 3107-3111.
9. Kisker O, Becker CM, Prox D, Fannon M, D'Amato R, Flynn E, et al. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 2001; 61: 7669-7674.
10. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997; 99: 2851-2857.
11. Nagabuchi E, Vanderkolk WE, Une Y. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma. J Pediatr Surg 1997; 32: 287-293.
12. Tjaima W, Van Marck E, Weyler J, Dirix L, Van Daele A, Goovaerts G, et al. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer 1998; 78: 170-174.
13. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13: 1686-1690.
14. Grummer R, Schwarzer F, Bainczyk K. Peritoneal endometriosis: validation of an in vivo model. Hum Reprod 2001; 16: 1763-1743.
15. Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue in to the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422-432.
16. Inan S, Kuscu NK, Vatansever S, Ozbilgin K, Sayham S. Increased vascular surface density in ovarian endometriosis. Gynecol Endocrinol 2003; 17: 143-150.
17. Ota H, Tanaka T. Stromal vascularization in the endomeiosis during adenomyosis. Microsc Res Tech 2003; 60: 445-449.
18. Schindl M, Birner P, Obermair A, Kiese L, Wenzl R. Increased microvessel density in adenomyosis uteri. Fertil Steril 2001; 75: 131-135.
19. Hull ML, Charnock-Jones DS, Chan CLK, Bruner-Tran KL, Osteen KG, Tom BDM, et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 2003; 88: 2889-2899.
20. Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL, et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004; 89: 1089-1095.
21. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404-407.
22. Wang JW, Sun Y, Liu YY, Yu QT, Zhang XP, Li K, et al. Results of randomized, multicenter, double blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients. Clin J Lung Cancer (Chin) 2005; 8: 283-290.
23. Dhanabal M, Volk R, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, et al. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun, 1999; 258: 345-352.
24. Kim YM, Hwang S, Kim YM, Pyun BJ, Kim TY, Lee ST, et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 2002; 277: 27872-27879.
25. Kim YM, Jang JW, Lee OH, Yeon J, Choi EY, Kim KW, et al. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase 2. Cancer Res 2000; 60: 5410-5413.
26. Rehn M, Veikkola T, Kukk-Valdre E, Nakamura H, Ilmonen M, Lombardo C, et al. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 2001; 98: 1024-1029.
27. Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B, et al. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem 2002; 277: 16464-16469.
28. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1907; 18: 24-25.
29. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L. Expression of vascular endothelial growth factor and thrombospondin-1mRNA in patients with endometriosis. Fertil Steril 2002; 78: 148-153.
30. Nisolle M, Casanas-Roux F, Donnez J. Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice. Fertil Steril 2000; 74: 306-312.